NYMX

Nymox Pharmaceutical Corp
NYMX

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

NYMX was delisted on the 6th of July, 2023.

Back to rankings

45 hedge funds and large institutions have $8.92M invested in Nymox Pharmaceutical Corp in 2019 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 12 increasing their positions, 18 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less call options, than puts

Call options by funds: $ | Put options by funds: $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

Holders
45
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$90K
Puts
$112K
Net Calls
Net Calls Change

Top Buyers

1
+$37.1K
2
+$35K
3
+$32.5K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$30.2K
5
Goldman Sachs
Goldman Sachs
New York
+$29.7K

Top Sellers

1
-$233K
2
-$126K
3
-$61.8K
4
PAG
Private Advisor Group
New Jersey
-$49K
5
FDCDDQ
Federation des caisses Desjardins du Quebec
Quebec, Canada
-$46.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$40K
27
$35K
28
$31K
29
$28K
30
$26K
31
$25K
32
$21K
33
$21K
34
$18K
35
$16K
36
$14K
37
$13.5K
38
$12K
39
$11K
40
$10K
41
$9K
42
$6K
43
$5K
44
$2K
45
$1K
46
–
47
–
48
–
49
–
1
2